Surveillance: Optimizing Performance to Meet Infection Prevention and ADE Compliance
Tina Moen, PharmD, Chief Clinical Officer, Clinicians, Thomson Reuters Healthcare. Surveillance and reporting of clinical data for Infection prevention (IP) and Adverse Drug Event (ADE) intervention can represent a significant and ongoing resource drain on clinical and IT staff. And, with Stage 2 Meaningful Use criteria recommending that evidence-based Clinical Decision Support (CDS) be available […]